Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -276.00x is 133% below its 4-year average of -118.37x, near the low end of its 4-year range (-331.90x–1.98x).
As of the fiscal period ended Monday, June 30, 2025. 66.66% below its 12-month average of -165.61x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2025 (2025-06-30): -276.00x.
INTEREST COVERAGE RATIO
-276.00x
INTEREST COVERAGE RATIO AVG TTM
-165.61x
INTEREST COVERAGE RATIO AVG 3Y
-123.62x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-66.66%
CURRENT VS 3Y AVG
-123.27%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-4229.41%
vs the sector median at left
NeuroSense Therapeutics Ltd.
Market Cap
$6.95M
Interest Coverage Ratio
-276.00x
TTM Avg
-165.61x
3Y Avg
-123.62x
5Y Avg
N/A
Market Cap
$6.97M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.87M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.07M
Interest Coverage Ratio
-496.55x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.82M
Interest Coverage Ratio
-10117.00x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.72M
Interest Coverage Ratio
-545.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.65M
Interest Coverage Ratio
-82777.81x
TTM Avg
11.97x
3Y Avg
11.97x
5Y Avg
11.97x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeuroSense Therapeutics Ltd. (NRSN) | $6.95M | -276.00x | -165.61x | -123.62x | N/A |
| Co-Diagnostics, Inc. (CODX)vs › | $6.97M | N/A | N/A | N/A | N/A |
| KALA BIO, Inc. (KALA)vs › | $7.00M | -11.95x | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.87M | N/A | N/A | N/A | N/A |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | -496.55x | N/A | N/A | N/A |
| Exicure, Inc. (XCUR)vs › | $6.82M | -10117.00x | N/A | N/A | N/A |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.72M | -545.69x | N/A | N/A | N/A |
| Longeveron Inc. (LGVN)vs › | $7.18M | N/A | N/A | N/A | N/A |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.65M | -82777.81x | 11.97x | 11.97x | 11.97x |
| Aclarion, Inc. (ACON)vs › | $6.60M | N/A | N/A | N/A | N/A |
Interest Coverage
-276.0x
Debt/Equity
N/A
Current Ratio
0.31
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-06-30 | -276.00x |
| 2025-03-31 | -276.00x |
| 2024-12-31 | -59.03x |
| 2024-09-30 | -51.39x |
| 2024-03-31 | -1.24x |
| 2023-12-31 | 1.98x |
| 2023-09-30 | -241.42x |
| 2023-06-30 | -12.60x |
| 2023-03-31 | -9.65x |
| 2022-09-30 | -331.90x |
| 2022-06-30 | -102.57x |
| 2022-03-31 | -141.91x |
| 2021-12-31 | -1.42x |
| 2021-09-30 | -110.00x |
| 2021-03-31 | -162.38x |
